KCNH3 Polyclonal Antibody

The potassium voltage-gated channel subfamily H member 3 encoded by KCNH3 is a voltage-gated potassium channel alpha subunit predominantly expressed in the forebrain. Studies in mice have found that cognitive function increases when this gene is knocked out. In humans, the encoded protein has been shown to be capable of binding glycoprotein 120 of the human immunodeficiency virus type 1 (HIV-1) envelope. Two transcript variants encoding different isoforms have been found for this gene.

The KCNH3 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of KCNH3 protein expression. This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The KCNH3 Polyclonal Antibody is produced using high-quality materials and advanced techniques, ensuring superior performance and reproducibility. It exhibits a high affinity and specificity towards the KCNH3 protein, enabling accurate and precise detection even at low expression levels.

This antibody is suitable for use in a wide range of research areas, including neuroscience, cardiovascular biology, and drug discovery. It allows researchers to investigate the role of KCNH3 in various physiological and pathological processes, providing valuable insights into its function and potential therapeutic applications.

The KCNH3 Polyclonal Antibody is supplied as a liquid formulation, making it convenient and easy to use. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The antibody is also available in different sizes to meet the specific needs of different experiments and applications.

With its exceptional performance and reliability, the KCNH3 Polyclonal Antibody is an indispensable tool for researchers studying KCNH3 protein expression and its functional implications. It offers a valuable resource for advancing scientific knowledge and contributing to the development of novel therapeutic strategies.